Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E T Creagan

Showing results (11-20 of 112) with videos related to

Pageof 12
Sort By:
Cancer|August 15, 1983
A Phase I study of the combination N-(phosphonacetyl)-L-aspartate (PALA, NSC-224131) and L-alanosine (NSC-153353) in patients with advanced cancerE T Creagan, M J O'Connell, J S Kovach
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Pilot study of a continuous five-day intravenous infusion of etoposide concomitant with cisplatin in selected patients with advanced cancerE T Creagan, R L Richardson, J S Kovach
Head & Neck Surgery|March 1, 1987
Phase II clinical trial of the combination VP-16, bleomycin, and cis-diamminedichloroplatinum in patients with advanced upper aerodigestive squamous cell carcinomaE T Creagan, M Chang, H J Long, et al.
Head & Neck Surgery|January 1, 1986
A phase II clinical trial of the combination mitomycin C, adriamycin, and cis-diamminedichloroplatinum in patients with advanced upper aerodigestive cancerE T Creagan, M Chang, H J Long, et al.
Cancer|December 1, 1988
Cisplatin-based chemotherapy for neoplasms arising from salivary glands and contiguous structures in the head and neckE T Creagan, J E Woods, J Rubin, et al.
Cancer Investigation|January 1, 1985
Continuous five-drug versus alternating three-drug and two-drug chemotherapy after five-drug or three-drug induction in extensive small cell lung cancerR T Eagan, S Frytak, E T Creagan, et al.
The Journal of Investigative Dermatology|December 1, 1990
Disseminated malignant melanoma and recombinant interferon: analysis of seven consecutive phase II investigationsE T Creagan, D J Schaid, D L Ahmann, et al.
Cancer|September 1, 1989
Phase I study of recombinant leukocyte A interferon (IFN-alpha 2A, Roferon-A) with doxorubicin in advanced malignant diseaseE T Creagan, S Frytak, H J Long, et al.
American Journal of Clinical Oncology|December 1, 1988
Recombinant interferons in the management of advanced malignant melanoma. Updated review of five prospective clinical trials and long-term respondersE T Creagan, D J Schaid, D L Ahmann, et al.
Cancer|January 1, 1988
Recombinant leukocyte A interferon with doxorubicin. A phase I study in advanced solid neoplasms and implications for hepatocellular carcinomaE T Creagan, H J Long, S Frytak, et al.
Pageof 12

Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
Cancer|August 15, 1983
A Phase I study of the combination N-(phosphonacetyl)-L-aspartate (PALA, NSC-224131) and L-alanosine (NSC-153353) in patients with advanced cancerE T Creagan, M J O'Connell, J S Kovach
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Pilot study of a continuous five-day intravenous infusion of etoposide concomitant with cisplatin in selected patients with advanced cancerE T Creagan, R L Richardson, J S Kovach
Head & Neck Surgery|March 1, 1987
Phase II clinical trial of the combination VP-16, bleomycin, and cis-diamminedichloroplatinum in patients with advanced upper aerodigestive squamous cell carcinomaE T Creagan, M Chang, H J Long, et al.
Head & Neck Surgery|January 1, 1986
A phase II clinical trial of the combination mitomycin C, adriamycin, and cis-diamminedichloroplatinum in patients with advanced upper aerodigestive cancerE T Creagan, M Chang, H J Long, et al.
Cancer|December 1, 1988
Cisplatin-based chemotherapy for neoplasms arising from salivary glands and contiguous structures in the head and neckE T Creagan, J E Woods, J Rubin, et al.
Cancer Investigation|January 1, 1985
Continuous five-drug versus alternating three-drug and two-drug chemotherapy after five-drug or three-drug induction in extensive small cell lung cancerR T Eagan, S Frytak, E T Creagan, et al.
The Journal of Investigative Dermatology|December 1, 1990
Disseminated malignant melanoma and recombinant interferon: analysis of seven consecutive phase II investigationsE T Creagan, D J Schaid, D L Ahmann, et al.
Cancer|September 1, 1989
Phase I study of recombinant leukocyte A interferon (IFN-alpha 2A, Roferon-A) with doxorubicin in advanced malignant diseaseE T Creagan, S Frytak, H J Long, et al.
American Journal of Clinical Oncology|December 1, 1988
Recombinant interferons in the management of advanced malignant melanoma. Updated review of five prospective clinical trials and long-term respondersE T Creagan, D J Schaid, D L Ahmann, et al.
Cancer|January 1, 1988
Recombinant leukocyte A interferon with doxorubicin. A phase I study in advanced solid neoplasms and implications for hepatocellular carcinomaE T Creagan, H J Long, S Frytak, et al.
Pageof 12